These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31637907)

  • 1. Repurposing Peptidomimetic as Potential Inhibitor of New Delhi Metallo-β-lactamases in Gram-Negative Bacteria.
    Liu Y; Yang K; Jia Y; Wang Z
    ACS Infect Dis; 2019 Dec; 5(12):2061-2066. PubMed ID: 31637907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
    Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
    Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin Analogue Restores Meropenem Activity against NDM-1 Gram-Negative Pathogens.
    Yarlagadda V; Sarkar P; Samaddar S; Manjunath GB; Mitra SD; Paramanandham K; Shome BR; Haldar J
    ACS Infect Dis; 2018 Jul; 4(7):1093-1101. PubMed ID: 29726673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Mercapto Propionamide Derivatives with Potent New Delhi Metallo-β-Lactamase-1 Inhibitory Activity and Low Toxicity.
    Meng Z; Tang ML; Yu L; Liang Y; Han J; Zhang C; Hu F; Yu JM; Sun X
    ACS Infect Dis; 2019 Jun; 5(6):903-916. PubMed ID: 30838850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a newly developed immunochromatographic assay for NDM-type metallo-β-lactamase producing Gram-negative pathogens in Myanmar.
    Tada T; Sekiguchi JI; Watanabe S; Kuwahara-Arai K; Mizutani N; Yanagisawa I; Hishinuma T; Zan KN; Mya S; Tin HH; Kirikae T
    BMC Infect Dis; 2019 Jun; 19(1):565. PubMed ID: 31253101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance.
    King AM; Reid-Yu SA; Wang W; King DT; De Pascale G; Strynadka NC; Walsh TR; Coombes BK; Wright GD
    Nature; 2014 Jun; 510(7506):503-6. PubMed ID: 24965651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Repurposing of the Unithiol: Inhibition of Metallo-β-Lactamases for the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections.
    Grigorenko VG; Khrenova MG; Andreeva IP; Rubtsova MY; Lev AI; Novikova TS; Detusheva EV; Fursova NK; Dyatlov IA; Egorov AM
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
    Zhang J; Wang S; Wei Q; Guo Q; Bai Y; Yang S; Song F; Zhang L; Lei X
    Bioorg Med Chem; 2017 Oct; 25(19):5133-5141. PubMed ID: 28784300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
    Muteeb G; Alsultan A; Farhan M; Aatif M
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Delhi metallo-β-lactamase (NDM-1): an update.
    Shakil S; Azhar EI; Tabrez S; Kamal MA; Jabir NR; Abuzenadah AM; Damanhouri GA; Alam Q
    J Chemother; 2011 Oct; 23(5):263-5. PubMed ID: 22005056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Inhibitors Against NDM-1 Type Metallo-β-Lactamases: An Overview.
    Sharma S; Sharma S; Singh PP; Khan IA
    Microb Drug Resist; 2020 Dec; 26(12):1568-1588. PubMed ID: 32486911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem.
    Tehrani KHME; Martin NI
    ACS Infect Dis; 2017 Oct; 3(10):711-717. PubMed ID: 28820574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acylhydrazones confer inhibitory efficacy against New Delhi metallo-β-lactamase-1.
    Gao H; Li JQ; Kang PW; Chigan JZ; Wang H; Liu L; Xu YS; Zhai L; Yang KW
    Bioorg Chem; 2021 Sep; 114():105138. PubMed ID: 34229201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypyridine ligands as potential metallo-β-lactamase inhibitors.
    La Piana L; Viaggi V; Principe L; Di Bella S; Luzzaro F; Viale M; Bertola N; Vecchio G
    J Inorg Biochem; 2021 Feb; 215():111315. PubMed ID: 33285370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H
    Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
    Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli.
    Li X; Zhao D; Zhao X; Cheng P; Li F; Sun J; Li Y; Bai J; Zhang X
    Eur J Med Chem; 2023 Mar; 250():115225. PubMed ID: 36870273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens.
    Karaiskos I; Galani I; Souli M; Giamarellou H
    Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):133-149. PubMed ID: 30626244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
    Guo Y; Yang Y; Xu X; Li L; Zhou Y; Jia G; Wei L; Yu Q; Wang J
    Eur J Med Chem; 2022 Mar; 231():114108. PubMed ID: 35101651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.
    Hu L; Yang H; Yu T; Chen F; Liu R; Xue S; Zhang S; Mao W; Ji C; Wang H; Xie H
    Eur J Med Chem; 2022 Mar; 232():114174. PubMed ID: 35152091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.